XML 12 R2.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Net sales $ 484.8 $ 500.2
Cost of products sold 412.2 416.2
Gross profit 72.6 84.0
Selling and general expense 63.3 61.6
Research and development expense 6.3 6.0
Intangible asset amortization expense 15.4 15.8
Total nonmanufacturing expenses 85.0 83.4
Goodwill impairment expense 411.9 0.0
Restructuring and other impairment expense 6.3 14.4
Operating loss (430.6) (13.8)
Interest expense 17.8 18.3
Other income (expense), net (1.8) 1.7
Loss before income taxes (450.2) (30.4)
Income tax benefit, net (24.7) (2.4)
Net loss $ (425.5) $ (28.0)
Net loss per share:    
Basic (in dollars per share) $ (7.82) $ (0.52)
Diluted (in dollars per share) $ (7.82) $ (0.52)
Weighted average shares outstanding:    
Basic (in shares) 54,447,200 54,267,900
Diluted (in shares) 54,447,200 54,267,900